NF-κB, a prototypical cytokine-regulated transcription factor: Implications for alcohol-mediated responses

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 8 SUPPL., 1996, Pages

  Zakhari, Samir ^a   Szabo, Gyongyi ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ALCOHOL CONSUMPTION; CONFERENCE PAPER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM;

EID: 0029829038     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01783.x     Document Type: Conference Paper

References (60)

1. Grilli M, Chiu J-S, Lenardo M: NF-κB and Rel, Participants in a multiform transcriptional regulatory system. In International Review of Cytology. A Survey of Cell Biology. San Diego, CA, Academic Press, 1993, pp1-62
2. Baeuerle P, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179,1994
3. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956-959, 1994
4. Verma IM, Stevenson JK, Schwartz EM, Van Antwerp D, Miyamoto S: Rel/ NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev 9: 2723-2735, 1995
5. Baeuerle PA, Baltimore D: Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53:211-217, 1988
6. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S: IκB-beta regulates the persistent response in a biphasic activation of NF-κB. Cell 80: 573-582, 1995
7. Zabel U, Baeuerle PA: Purified human IB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell 61: 255-265, 1990
8. Thanos D, Maniatis T: Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 15-152-164, 1995
9. de Martin R, Vanhove B, Cheng Q, Hofer E: Cytokine-inducible expression in endothelial cells of an IKBα-like gene is regulated by NF-κB. EMBO J 12: 2773-2779, 1993
10. LeBail O, Schmidt-Ullrich R, Israel A: Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: Positive regulation by members of the rel/ NF-κB family. EMBO J 12: 5043-5049, 1993
11. Su Yang H, Phillips RJ, Douglas I, Ghosh S: The role of unphosphorylated newly synthesized IB- in the persistent activation of NF-κB. Mol Cell Biol 1996 (in press)
12. Van Snick J: Interleukin-6: An overview. Annu Rev Immunol 8: 253-278, 1990
13. Libermann T, Baltimore D: Activation of interleuldn-6 gene expression through the NF-κB transcription factor. Mol Cell Biol 10: 2327-2334, 1990
14. Shimizu H, Mitotmo K, Watanabe T, Okamoto S, Yamamoto K: Involvement of a NF-κB -like transcription factor in the activation of the interleukin- 6 gene by inflammatory lymphokines. Mol Cell Biol 10: 561-568, 1990
15. Zhang Y, Lin J-X, Vilcek J: Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol 10: 3818-3823, 1990
16. Szabo G, Mandrekar P, Catalano D: Inhibition of superantigen-induced T cell proliferation and monocyte IL- I B, TNFA, and IL-6 production by acute ethanol treatment. J Leuk Biol 58, 342-351, 1995
17. Collart MA, Baeuerle P, Vassali P: Regulation of tumor necrosis factor alpha transcription in macrophages. Involvement of four NF-KB motifs and constitutive and inducible form of NF-κB. Mol Cell Biol 10: 1478-1506, 1990
18. Ahakhov AN, Collart MA, Vassali P, Nedospasou SA, Jongenel CV: kappa B-type enhancers are involved in LPS-mediated transcriptional activation of the TNFA gene in primary macrophages. J Exp Med 171:35-47, 1990
19. Beg AA, Baldwin AS: The IB proteins: Multifunctional regulators of Rel/ NF-κB transcription factors. Genes Dev 7:2064-2070, 1993
20. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgrass P, Streensdorf T, Baeuerle P, Haas IG, Reithmuller G: Tolerance to lypopolysaccaride involves mobilization of nuclear factor kB with predominance of p5O monodimers, J Biol Chem 269:17001-17004, 1994
21. Szabo G, Verma B, Catalano D: Selective inhibition of antigen-specific T lymphocyte proliferation by acute ethanol exposure: the role of impaired monocyte antigen presentation capacity and mediator production. J Leuk Biol 54:534-544,1993
22. Szabo G, Mandrekar P, Verma B, Caulano D: Modulation of cytokine production in human lymphoid and myeloid cells by alcohol in vitro, in Watson R R (ed): Alcohol, Drugs of Abuse and Immune Function. Tanytown, NY, Pergamon Press, 1995, pp 105-119
23. Thanos D, Maniatis T: The high mobility group protein HMG I(Y) is required for NF-κB -dependent virus indiction of the human IFN-β gene. Cell 71:777-789, 1992
24. Cybulsky MI, Gimbrone MA,Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during alherogenesis. Science 251:788-791, 1991
25. Elices MJ, Osbom L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577-84, 1990
26. Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, Derse ACP, Klunk D, Schleimer RP: Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 173:1553-1557, 1991
27. Burkly LC, Jakubowski A, Newman BM, Rosa MD, Chi RG, Lobb RR: Signaling by vascular cell adhesion molecules (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation. Eur J Inimunol 21:2871-2875, 1991
28. Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, Harlan J: Human monocyte s bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: Endothelial-leukocyte adhesion molecules and vascular cell adhesion molecule-1. Blood 77:2266-2271, 1991
29. Oppenheimer MN, Davis LS, Bogue DT, Ramberg J, Lipsky PE: Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 147:2913-2921, 1991
30. van Dinther Janssen AC, Horst E, Koopman G, Newmann W, Scheper RJ, Meijer CJ, Pals ST: The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium; J Immunol 147:4207-4210, 1991
31. Morel DW, DiCorleto PE, Chisolm GM: Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4:357-364, 1984
32. Sparrow CP, Olszewski J: Cellular oxidative modification of low density lipoprotein does not require lipoxygenases. Proc Natl Acad Sci USA 89:128-131, 1992
33. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habemehl GG: Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem J 263:539-545, 1989
34. Warner BB, Burhans MS, Clark JC, Wispe JR: Tumor necrosis factor-alpha increases Mn-SOD expression: Protection against oxidant injury. Am J Physiol 260:L296-301, 1991
35. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule- 1 (VCAM- 1). J Biol Chem 267:16323-16329, 1992
36. Schreck R, Baeuerle P: A role for oxygen radicals as second messengers.Trends Cell Biol 1:39-42, 1991
37. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258, 1991
38. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM: VCAM-1 gene transcription and expression is regulated through an antioxidant sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874, 1993
39. Xanthoudakis S, Miao G, Wang F, Pan Y-C E, Curran T: Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 11:3323-3335, 1992
40. Stein B, Baldwin A, Ballard D, Greene W, Angel P, Herrlich P: Cross-coupling of the NF-κB p65 and fos/jun transcription factors produces potentiated biological function. EMBO J 12:3879-3891, 1993
41. Khan B, Ollbrych M, Parthasarathy S, Alexander R, Medford R: Polyunsaturated fatty acids are selective, redox sensitive regulators of VCAM-1 gene expression in human vascular endothelial cells. Circulation 90:i82, 1994 (abstr)
42. Hill CS, Triesman R: Transcriptional regulation by extracellular signals: Mechanisms and specificty. Cell 80:199-212, 1995
43. Derijard B, Hibi M, Wu IH: JNK1: A protein kinases stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1038, 1994
44. Sanchez I, Hughes RT, Mayer BJ: Role of SAPK/ERK kinase-l in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:794-798, 1994
45. Westwick JK, Weitzel C, Leffert HL, Brenner DA: Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Junkinase, J Biol Chem 269:26396-26401, 1994
46. Angel P, Karin M: The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochim Biophys Acta 102:129-157, 1991
47. Damell J, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to interferons and other extracellular signalling proteins. Science 264:1415-1421, 1994
48. Sadowski HB, Shuai K, Damell JE, Gilman MZ: A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739-1744, 1993
49. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504, 1995
50. Menon SD, Guy GR, Tan YH: Involvement of a putative protein-tyrosine phosphatase and I kappa B-alpha serine phosphorylation in nuclear factorkappa B activation. J Biol Chem 270:18881-18887, 1995
51. O'Connell MA, Cleere R, Long A, O'Neill LA, Kelleher D: Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT78. J Biol Chem 270:7399-7404, 1995
52. McClain CJ, Cohen DA, Dinarello CA: Serum interleukin-1 (IL-1) activity in alcoholic hepatitis, Life Sci 39:1479-1485, 1986
53. Hill D, Marsano L, Cohen D: Increased plasma interleukin 6 activity in alcoholic hepatitis. J Lab Clin Med 119:547-551, 1992
54. Hill DB, Marsano LS, McClain CJ: Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepalology 18:576-580, 1993
55. Korhuts A, Stahnke L, McClain CJ: Circulating tumor necrosis factor, interleukin 1 and interleukin 6 concentrations in chronic alcoholics. Hepatology 13:267-272, 1991
56. Felver ME, Mezey E, McGuire M: Plasma tumor necrosis factor -alpha predicts decreased long term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255-259, 1990
57. Bird GLA, Sheron N, Goka AKJ: Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917-921, 1990
58. Benbrook DM, Jones NC: Heterodimer formation between CREB and JUN proteins. Oncogene 5:295-402, 1992
59. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′, 5′-monophasphate. Science 262:1065-1069, 1993
60. Diehl AM, Yin M, Fleckenstein J: Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol 267:G552-G561, 1994